Operator of a biotechnology company intended for cardiovascular and cardiopulmonary curative gene therapies. The company specializes in the development of curative gene remedies for genetic and acquir...

Healthcare
Heidelberg, Germany
Founded 2019
11 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$24.8M
Last Round
N/A

Get the full picture

Create a free account to unlock AaviGen's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required